Sarsia
Venture capital · Bergen, Norway · Europe
Sarsia is an early-stage venture capital firm that invests in life sciences and in technology, energy and sustainability. It takes board positions in portfolio companies and supports them through progressive rounds of capitalisation.
Invests inHealthcare & BiotechIndustrial & Manufacturing
In its own wordslife scienceshealthcaretechnologyenergysustainabilitygreen transition
Your fit with Sarsia
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsSarsia lists 26 checked portfolio companies on its own site and is named in 3 funding rounds, 1 of them as lead. Its most frequent entry is Seed, 100% of the companies with a known first round. Its largest themes are Healthcare & Biotech (32%), Industrial & Manufacturing (16%) and AI & Machine Learning (14%). 86% of its companies are based in Norway. It invests most often alongside Investinor, Birk Venture and Butterfly Ventures.
Counts come from funding rounds that name Sarsia, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Sarsia's whole history. Rounds on record name 3 companies; its own site lists 26. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 100% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 2 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 62th | 26 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 100th | 100% of entries at pre-seed or seed |
| Evidence | 60th | 4% of companies confirmed by a round |
| Sector focus | 58th | 32% in its largest sector |
| Reach | 58th | 3 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 32% | 15% |
| Industrial & Manufacturing | 16% | 7% |
| AI & Machine Learning | 14% | 18% |
| E-commerce & Marketplaces | 8% | 6% |
| Climate & Energy | 5% | 1% |
| Education | 5% | 7% |
| Fintech | 3% | 12% |
| Consumer | 3% | 3% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Investinor | 4 |
| Birk Venture | 2 |
| Butterfly Ventures | 2 |
| Farvatn Venture | 2 |
| Antler | 1 |
| BackingMinds | 1 |
| CoFounder | 1 |
| Eviny Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2596%
- No longer answers00%
- Points to another company14%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare Sarsia head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Sarsia| Date | Company | Stage |
|---|---|---|
| 2 Sept 2026 | Seed | |
| 17 Aug 2026 | Seed Led | |
| 1 Nov 2025 | Seed |
Round details for Sarsia
Amounts, full round histories and every co-investor in Sarsia's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
26 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| APIM Therapeutics is a clinical-stage oncology company developing first-in-class PCNA-targeting therapeutics. | Healthcare & Biotech | Portfolio page | ||
| BerGenBio was developing first-in-class AXL inhibitors for aggressive disease | Healthcare & Biotech | Portfolio page | ||
| Birdsview provides 3D concrete scanning and rebar mapping services using non-destructive methods like ground penetrating radar and 3D tracking. | Consumer | Aug 2026Seed | Funding round | |
| Cetasol provides a maritime monitoring and analytics platform for vessel performance and fuel consumption tracking | Industrial & ManufacturingAI & Machine Learning | Nov 2025Seed | Page + round | |
| Elekt provides a customer platform for the electricity industry | E-commerce & MarketplacesEnterprise Software | Portfolio page | ||
| The company provides energy products and services to private customers. | EducationE-commerce & Marketplaces | Portfolio page | ||
| Enua designs and manufactures electric vehicle charging solutions for various facilities and homes. | E-commerce & MarketplacesIndustrial & Manufacturing | Portfolio page | ||
| Flow Computing enables next generation SuperCPUs with its Parallel Processing Unit (PPU) technology | Healthcare & BiotechRobotics & Hardware | Portfolio page | ||
| GeneSeque is developing break-through technology for single-molecule DNA sequencing | Healthcare & Biotech | Portfolio page | ||
| The company operates a marketplace for buying, selling, and tracking renewable energy certificates. | EducationClimate & Energy | Portfolio page | ||
| Mitigrate helps insurers prevent losses by identifying properties at risk of flooding and determining the most effective measures to prevent damage. | FintechClimate & Energy | Portfolio page | ||
| Naeva provides a digital platform for construction sites to manage and control various aspects of the site, including climate and energy, access control, and analysis tools. | Real Estate & ConstructionIndustrial & Manufacturing | Sept 2026Seed | Funding round | |
| Nisonic develops medical software for non-invasive detection of intracranial pressure using ultrasound imaging and machine learning | Healthcare & Biotech | Portfolio page | ||
| Nykode Therapeutics develops immunotherapy treatments, including a platform built around the Vaccibody molecule, to treat diseases such as cancer and autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
| Oculaudio AS is a company that develops hearing aid solutions | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Pluvia develops innovative therapies to help patients suffering from rare genetic disorders | Healthcare & Biotech | Portfolio page | ||
| Qbee provides an IoT device management platform for automating and scaling device operations | Industrial & ManufacturingCybersecurity | Portfolio page | ||
| Scandinavian Biopharma is a research-based specialty biopharma company that develops and distributes biopharmaceutical products, including vaccines and immunoglobulins. | Healthcare & Biotech | Portfolio page | ||
| ScreenCancer AS offers various forms of cancer screening to businesses and private individuals. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- sarsia.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 1 Nov 2025
- Companies checked
- 26
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Sarsia's profile as data
Pull Sarsia's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/sarsia.com
# also
GET /v1/firms/sarsia.com/portfolio
GET /v1/firms/sarsia.com/coinvestors
GET /v1/firms/sarsia.com/news